David Cox
- Business and International Management top 0.05%
- Aging top 0.1%
- Molecular Biology top 0.05%
- CRISPR and Genetic Engineering 16
- RNA and protein synthesis mechanisms 8
- Advanced biosensing and bioanalysis techniques 6
- Genomics and Chromatin Dynamics 3
- RNA regulation and disease 3
- Genetics top 0.1%
- Genomic variations and chromosomal abnormalities 4
- Insect Science top 0.2%
-
- Canadian Policy and Governance 4
-
- Diagnosis and Treatment of Venous Diseases 4
- Co-authors
- Feng ZhangWenyan JiangLuciano A. MarraffiniNaomi HabibPatrick D. HsuXuebing WuLe CongF. Ann Ran
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
David Cox
66 papers receiving 24.6k citations
Hit Papers
Peers
Comparison fields: 5 of 186
- Business and International Management 1.7k
- Aging 1.1k
- Molecular Biology 20.5k
- Genetics 4.6k
- Insect Science 1.4k
Countries citing papers authored by David Cox
This map shows the geographic impact of David Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cox more than expected).
Fields of papers citing papers by David Cox
This network shows the impact of papers produced by David Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cox. The network helps show where David Cox may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Cox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 0 | |
| 6 | 2021 | 1 | |
| 7 | A cytosine deaminase for programmable single-base RNA editingbreakdown → | 2019 | 332 |
| 8 | RNA editing with CRISPR-Cas13breakdown → | 2017 | 1291 |
| 9 | Engineered Cpf1 variants with altered PAM specificities | 2017 | 1 |
| 10 | Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28breakdown → | 2017 | 434 |
| 11 | C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effectorbreakdown → | 2016 | 1689 |
| 12 | CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus | 2015 | 7 |
| 13 | Multiplex Genome Engineering Using CRISPR/Cas Systemsbreakdown → | 2013 | 11236 |
| 14 | Mental health. End of the line for outpatient clinics. | 2013 | 1 |
| 15 | 2013 | 10 | |
| 16 | 2011 | 5 | |
| 17 | Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseasebreakdown → | 2008 | 2456 |
| 18 | 2005 | 14 | |
| 19 | 1999 | 39 | |
| 20 | 1965 | 237 |
About David Cox
David Cox is a scholar working on Business and International Management, Genetics and Molecular Biology, having authored 81 papers that have together received 25.2k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (16 papers), RNA and protein synthesis mechanisms (8 papers), Advanced biosensing and bioanalysis techniques (6 papers), Canadian Policy and Governance (4 papers), Genomic variations and chromosomal abnormalities (4 papers), Diagnosis and Treatment of Venous Diseases (4 papers), Genomics and Chromatin Dynamics (3 papers) and RNA regulation and disease (3 papers). The work is most often cited by research in Business and International Management (1.7k citations), Aging (1.1k citations) and Molecular Biology (20.5k citations). David Cox has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Feng Zhang, Wenyan Jiang, Luciano A. Marraffini, Naomi Habib, Patrick D. Hsu, Xuebing Wu, Le Cong, F. Ann Ran, Robert P. J. Barretto and Jonathan S. Gootenberg. Their work appears in journals such as Science, Nature, Genome Research, Cancer and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.